大鼠缺血性卒中后延迟24小时肌注神经营养因子3的恢复研究
研究在大鼠单侧缺血性卒中模型中,模拟临床可行时间窗(24小时后)经植入导管和微量泵向患侧肱三头肌输注NT3蛋白4周。结果显示NT3可穿过血脑屏障,改善前肢放置准确性和患肢支撑使用,逆转腕部感觉障碍,并诱导皮质脊髓和血清素能通路可塑性,提示外周延迟输注NT3可促进卒中后感觉运动功能恢复。
要点
- 卒中后24小时开始外周输注NT3蛋白可改善大鼠前肢感觉运动功能。
- NT3可穿越血脑屏障进入脑和脊髓,并诱导皮质脊髓和血清素能通路可塑性。
- 外周高剂量NT3在既往I/II期临床试验中安全耐受,为卒中治疗提供转化依据。
核心结论
- 延迟的外周NT3输注可改善缺血性卒中后的感觉运动功能。
研究设计与样本
- 大鼠单侧感觉运动皮层缺血性卒中模型,24小时后随机接受NT3或溶剂经植入导管和微量泵输注患侧肱三头肌4周。
主要发现
- 放射性标记NT3在有无卒中的啮齿类动物中均从血流进入脑和脊髓。
- NT3提高水平梯行走时前肢放置准确性并增加患肢用于侧向支撑。
- NT3逆转患侧腕部感觉障碍。
- 功能磁共振显示梗死周围BOLD信号自发恢复,NT3未进一步增强。
- NT3诱导 spared 皮质脊髓和血清素能通路的神经可塑性。
临床怎么用
- 支持外周延迟输注NT3作为卒中后感觉运动恢复的潜在转化治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Neurotrophin-3 (NT3) plays a key role in the development and function of locomotor circuits including descending serotonergic and corticospinal tract axons and afferents from muscle and skin. We have previously shown that gene therapy delivery of human NT3 into affected forelimb muscles improves sensorimotor recovery after stroke in adult and elderly rats. Here, to move toward the clinic, we tested the hypothesis that intramuscular infusion of NT3 protein could improve sensorimotor recovery after stroke. METHODS: Rats received unilateral ischemic stroke in sensorimotor cortex. To simulate a clinically feasible time to treatment, 24 hours later rats were randomized to receive NT3 or vehicle by infusion into affected triceps brachii for 4 weeks using implanted catheters and minipumps. RESULTS: Radiolabeled NT3 crossed from the bloodstream into the brain and spinal cord in rodents with or without strokes. NT3 increased the accuracy of forelimb placement during walking on a horizontal ladder and increased use of the affected arm for lateral support during rearing. NT3 also reversed sensory impairment of the affected wrist. Functional magnetic resonance imaging during stimulation of the affected wrist showed spontaneous recovery of peri-infarct blood oxygenation level-dependent signal that NT3 did not further enhance. Rather, NT3 induced neuroplasticity of the spared corticospinal and serotonergic pathways. INTERPRETATION: Our results show that delayed, peripheral infusion of NT3 can improve sensorimotor function after ischemic stroke. Phase I and II clinical trials of NT3 (for constipation and neuropathy) have shown that peripheral high doses are safe and well tolerated, which paves the way for NT3 as a therapy for stroke. ANN NEUROL 2019;85:32-46.
引用
- Duricki DA, Drndarski S, Bernanos M, et al. Stroke Recovery in Rats after 24-Hour-Delayed Intramuscular Neurotrophin-3 Infusion. Ann Neurol. 2018. PMID: 30525223. doi:10.1002/ana.25386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。